Telix Pharmaceuticals Limited Stock Price on December 4, 2024
| TLX Stock | 15.77 0.53 3.25% |
Below is the normalized historical share price chart for Telix Pharmaceuticals Limited extending back to November 20, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Telix Pharmaceuticals stands at 15.77, as last reported on the 12th of December 2024, with the highest price reaching 17.30 and the lowest price hitting 15.70 during the day.
If you're considering investing in Telix Stock, it is important to understand the factors that can impact its price. Telix Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.094, which indicates the firm had a 0.094% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Telix Pharmaceuticals Limited, which you can use to evaluate the volatility of the company. Please review Telix Pharmaceuticals' Risk Adjusted Performance of 0.0734, semi deviation of 1.58, and Coefficient Of Variation of 1089.87 to confirm if our risk estimates are consistent with your expectations.
Common Stock Shares Outstanding is likely to rise to about 331.5 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 85.3 M in 2024. . Price To Sales Ratio is likely to drop to 0.41 in 2024. Price Earnings Ratio is likely to drop to -5.53 in 2024. Telix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of November 2024 | 200 Day MA 15.5801 | 50 Day MA 15.5801 | Beta 2.384 |
Telix |
Sharpe Ratio = 0.094
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.58 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Telix Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telix Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 20.9816 | Enterprise Value Ebitda 110.9286 | Price Sales 8.45 | Shares Float 282.3 M | Wall Street Target Price 20.6248 |
Related Headline
Viking Therapeutics Headline on 4th of December 2024
Eli Lillys Zepbound Leads to Greater Weight Loss vs. Novo No... by medcitynews.com
Eli Lilly obesity drug Zepbound led to 47 percent greater relative weight loss compared to Wegovy in a head-to-head clinical trial. The results could help Lilly differentiate its product from Novo Nordisks in the increasingly competitive market of obesity medications.
Telix Pharmaceuticals Valuation on December 4, 2024
It is possible to determine the worth of Telix Pharmaceuticals on a given historical date. On December 4, 2024 Telix was worth 16.42 at the beginning of the trading date compared to the closed value of 16.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Telix Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Telix Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Telix Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Telix Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 16.90 | 16.90 | 16.19 | 16.19 | 20,200 | |
12/04/2024 | 16.42 | 17.20 | 16.25 | 16.35 | 38,989 |
| 16.30 | 16.30 | 16.00 | 16.00 | 18,421 |
| Backtest Telix Pharmaceuticals | | | Telix Pharmaceuticals History | | | Telix Pharmaceuticals Valuation | Previous | Next |
Telix Pharmaceuticals Trading Date Momentum on December 4, 2024
| On December 05 2024 Telix Pharmaceuticals Limited was traded for 16.00 at the closing time. Highest Telix Pharmaceuticals's price during the trading hours was 16.30 and the lowest price during the day was 16.00 . The net volume was 18.4 K. The overall trading history on the 5th of December contributed to the next trading period price depreciation. The trading price change to the next next day price was 2.14% . The trading price change to current price is 2.14% . |
Telix Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Telix Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Telix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Telix Pharmaceuticals Stock history
Telix Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telix Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telix Pharmaceuticals stock prices may prove useful in developing a viable investing in Telix Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 323.7 M | 331.5 M |
Telix Pharmaceuticals Stock Technical Analysis
Telix Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Telix Pharmaceuticals Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Telix Pharmaceuticals Limited cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Telix Pharmaceuticals December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Telix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telix Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Telix Pharmaceuticals stock market strength indicators, traders can identify Telix Pharmaceuticals Limited entry and exit signals to maximize returns
Telix Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Telix Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Telix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0734 | |||
| Jensen Alpha | 0.2189 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0521 | |||
| Treynor Ratio | 21.57 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.